Skip to content

A Preliminary Case Study of Brain Activity Measurement of Head Laser Acupuncture

A Preliminary Case Study of Brain Activity Measurement of Head Laser Acupuncture

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0011135
Enrollment
10
Registered
2025-11-11
Start date
2025-11-14
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : Application of laser acupuncture – Using two laser acupuncture instruments, apply to 100mW low power mode for 30 seconds simultaneously for Baihui(GV20) and Shangxing(GV23). Repeat

Sponsors

Kyung Hee University Oriental Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Among men and women aged 19 to under 65, those who have experienced headaches in the past six months 2. Those who have confirmed that there are no functional/substrate diseases or clinically meaningful findings through medical history and physical examination 3. Those who voluntarily agree in writing to participate in a clinical study by the patient himself/herself or his/her legal representative

Exclusion criteria

Exclusion criteria: 1. Those who have been evaluated as 56 points or higher through Headache Impact Test-6. 2. Those who are difficult to participate in the study because the participant himself/herself or his/her legal representative do not understand the consent form or do not understand the main contents of the study 3. Those who have a history of neurological diseases (traumatic brain injury, epilepsy, dementia, etc.) or neurological diseases in childhood 4. Those who have psychotic features such as delusions, hallucinations, etc. or have a past history 5. Those who have a systemic disease (e.g., endocrine or metabolic disease) that can affect the central nervous system 6. Those who have a alcohol or substance abuse or dependence 7. Those who take drugs that may affect their headaches and central nervous system (such as migraine drugs, migraine prevention drugs, dementia drugs, thyroid hormones, central nerve stimulants, antipsychotics, anticholinergics, and other psychiatric drugs) 8. An uncontrolled hypertensive patient 9. Those who are pregnant or nursing 10. Those who are currently participating in other clinical trials or participating in other clinical trials within 30 days as of the screening date 11. If the clinical trial investigator determines that the participation of the clinical study is inappropriate MRI specific exclusion criteria 1. If there is a metal substance containing metal in the body (cardio-cerebrovascular stents, artificial pacemakers, cochlear implant, or braces worn, 3 or more implants, etc.) 2. Where it is difficult to endure a confined space due to claustrophobia, etc.

Design outcomes

Primary

MeasureTime frame
(Headache Impact Test-6, HIT-6)

Secondary

MeasureTime frame
(MIgraine Disability ASsessment, MIDAS);EQ-5D-5L;MRI images and individual analysis results

Countries

Korea, Republic of

Contacts

Public ContactJiho Pyun

Kyung Hee University Oriental Medical Center

joep725@khu.ac.kr+82-2-958-9188

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026